Methods and Compositions for Preventing a Condition
AssigneeCyvax, Inc.
InventorRichard Markham
Life of this patent
Estimating the term…
Abstract
Provided herein are methods, compositions, and kits for preventing, inhibiting, reducing the severity of, or treating a disease or condition. A pharmaceutical composition provided herein can comprise a nucleic acid sequence encoding an antigen fused to an immune cell product, e.g., MIP-3α, and an adjuvant. The antigen can be from a bacteria, virus, fungus, parasite, or cancer. The antigen can be an Alzheimer's disease antigen.
Claims49
A pharmaceutical composition comprising:
- a. a nucleic acid sequence encoding an antigen or a fragment thereof fused to macrophage inflammatory protein 3 alpha or a fragment thereof;
- and
- b. an adjuvant.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A nucleic acid sequence encoding a parasite antigen fused to macrophage inflammatory protein 3 alpha.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method for eliciting an immune response in a subject comprising administering to the subject a pharmaceutical composition comprising a nucleic acid sequence encoding a parasite antigen or fragment thereof fused to an immune cell product.
(canceled)
(canceled)
(canceled)
-98. (canceled)
Dependencies are inferred from the claim text.